An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo
暂无分享,去创建一个
T. Nagayasu | M. Guo | Y. Naomoto | T. Tsuchiya | Koichi Tomoshige | W. Stuart | I. Fink-Baldauf | Yutaka Maeda | T. Fukazawa | K. Tomoshige
[1] A. Rudensky,et al. A nonimmune function of T cells in promoting lung tumor progression , 2017, The Journal of experimental medicine.
[2] A. Kiyatkin,et al. EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics , 2017, Cell.
[3] A. Redig,et al. Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2 , 2017, Nature Communications.
[4] S. Fouzas,et al. NRAS destines tumor cells to the lungs , 2017, EMBO molecular medicine.
[5] D. Coppola,et al. Preclinical Modeling of KIF5B–RET Fusion Lung Adenocarcinoma , 2016, Molecular Cancer Therapeutics.
[6] C. Lucchesi,et al. Secretion of protein disulphide isomerase AGR2 confers tumorigenic properties , 2016, eLife.
[7] J. Yokota,et al. Gene aberrations for precision medicine against lung adenocarcinoma , 2016, Cancer science.
[8] Haikuo Zhang,et al. Overcoming EGFR T790M and C797S resistance with mutant-selective allosteric inhibitors , 2016 .
[9] P. Lorenzo-Luaces,et al. A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients , 2016, Clinical Cancer Research.
[10] M. Meyerson,et al. NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination Therapy , 2015, Molecular Cancer Therapeutics.
[11] R. Prywes,et al. Pathway Regulation of p63, a Director of Epithelial Cell Fate , 2015, Front. Endocrinol..
[12] Jianqiang Mao,et al. ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and Metastasis , 2015, Cell reports.
[13] Thomas D. Wu,et al. A comprehensive transcriptional portrait of human cancer cell lines , 2014, Nature Biotechnology.
[14] Elizabeth A. Calle,et al. Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. , 2014, Cell stem cell.
[15] Timothy R. Fallon,et al. Yap tunes airway epithelial size and architecture by regulating the identity, maintenance, and self-renewal of stem cells. , 2014, Developmental cell.
[16] Steven J. M. Jones,et al. Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.
[17] William Pao,et al. AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. , 2014, Cancer discovery.
[18] Angela N. Brooks,et al. SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas. , 2014, The Journal of clinical investigation.
[19] Zhaoyuan Fang,et al. Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma , 2014, Nature Communications.
[20] Benjamin D. Medoff,et al. Dedifferentiation of committed epithelial cells into stem cells in vivo , 2013, Nature.
[21] Takeshi Nagayasu,et al. Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung. , 2012, The Journal of clinical investigation.
[22] Jane Fridlyand,et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors , 2012, Nature.
[23] U. Rapp,et al. Conditional expression of oncogenic C-RAF in mouse pulmonary epithelial cells reveals differential tumorigenesis and induction of autophagy leading to tumor regression. , 2011, Neoplasia.
[24] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[25] P. Jänne,et al. Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogene. , 2010, Cancer research.
[26] John R. Engen,et al. Novel mutant-selective EGFR kinase inhibitors against EGFR T790M , 2009, Nature.
[27] Issa J. Dahabreh,et al. Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC , 2009, Nature Reviews Clinical Oncology.
[28] M. Meyerson,et al. HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy , 2009, Proceedings of the National Academy of Sciences.
[29] Ralph Weissleder,et al. Effective Use of PI3K and MEK Inhibitors to Treat Mutant K-Ras G12D and PIK3CA H1047R Murine Lung Cancers , 2008, Nature Medicine.
[30] Jie Zhang,et al. Intratumoral Epiregulin Is a Marker of Advanced Disease in Non–Small Cell Lung Cancer Patients and Confers Invasive Properties on EGFR-Mutant Cells , 2008, Cancer Prevention Research.
[31] John D. Minna,et al. Deregulated EGFR Signaling during Lung Cancer Progression: Mutations, Amplicons, and Autocrine Loops , 2008, Cancer Prevention Research.
[32] Jiandie D. Lin,et al. TEAD mediates YAP-dependent gene induction and growth control. , 2008, Genes & development.
[33] A. R. Thitoff,et al. Conditional deletion of Pten causes bronchiolar hyperplasia. , 2008, American journal of respiratory cell and molecular biology.
[34] T. Mak,et al. Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. , 2007, The Journal of clinical investigation.
[35] R. Schmid,et al. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. , 2007, Cancer cell.
[36] W. Pao,et al. Development of New Mouse Lung Tumor Models Expressing EGFR T790M Mutants Associated with Clinical Resistance to Kinase Inhibitors , 2007, PloS one.
[37] D. Neil Hayes,et al. LKB1 modulates lung cancer differentiation and metastasis , 2007, Nature.
[38] M. Meyerson,et al. Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy. , 2007, Cancer cell.
[39] Levi A Garraway,et al. Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models. , 2007, Cancer research.
[40] Daniel A. Haber,et al. Epidermal growth factor receptor mutations in lung cancer , 2007, Nature Reviews Cancer.
[41] H. Varmus,et al. Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. , 2006, Genes & development.
[42] J. Whitsett,et al. PARP-2 Interacts with TTF-1 and Regulates Expression of Surfactant Protein-B* , 2006, Journal of Biological Chemistry.
[43] R. Wanke,et al. Betacellulin overexpression in transgenic mice causes disproportionate growth, pulmonary hemorrhage syndrome, and complex eye pathology. , 2005, Endocrinology.
[44] William C Hahn,et al. Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants , 2005, PLoS medicine.
[45] Daniel A. Haber,et al. Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways , 2004, Science.
[46] M. Yaffe,et al. TAZ Interacts with TTF-1 and Regulates Expression of Surfactant Protein-C* , 2004, Journal of Biological Chemistry.
[47] J. Tichelaar,et al. Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmonary fibrosis. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[48] H. Varmus,et al. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.
[49] R. Schmid,et al. Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. , 1998, Gastroenterology.
[50] E. Dmitrovsky,et al. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[51] J. Whitsett,et al. Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. , 1994, The Journal of clinical investigation.
[52] K. Sugimachi,et al. Prognostic implication of transforming growth factor alpha in adenocarcinoma of the lung--an immunohistochemical study. , 1991, British Journal of Cancer.
[53] R. Palmiter,et al. Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast , 1990, Cell.
[54] G. Merlino,et al. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas , 1990, Cell.
[55] I. Pastan,et al. Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. , 1987, Science.
[56] A. McCullough. Comprehensive genomic characterization of squamous cell lung cancers , 2013 .
[57] J. Whitsett,et al. Conditional expression of genes in the respiratory epithelium in transgenic mice: cautionary notes and toward building a better mouse trap. , 2009, American journal of respiratory cell and molecular biology.